Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center — Houston, Texas

Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Inoperable Solid Tumors or Lymphomas.

Sponsors: Alfasigma S.p.A..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center?

Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center conducted?

Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center has 1 clinical trials on record. Their work covers Inoperable Solid Tumors or Lymphomas.

Is Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center accredited by Crixeo Health?

Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.